United States Food & Drug Administration (USFDA) has concluded GMP inspection at MEDI-CAPS’s Wholly Owned Subsidiary Company - Medgel’s Madhya Pradesh manufacturing facility. The inspection was conducted from February 17, 2025 to February 21, 2025. At the conclusion of the inspection on February 21, 2025, form 483 was issued to the company.
There were no observations related to data integrity, and all the observations were procedural in nature. The company will work in close collaboration with the agency to address the observations and will respond to the USFDA within stipulated timeline.
Medi-Caps incorporated in 1986 is a flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: